Skip to main content

High priority crop protection control gaps in various crops and finding alternatives for chemistry being phased out are the focus of residue and efficacy trial work this season. 

Ten trials have already been approved as part of the A Lighter Touch (ALT) programme’s residue and efficacy work for the coming season, with further trials still being finalised. 

ALT transition technical lead Bruno Gatimel says the efficacy of novel insecticides and softer biological options, which are essential to support sustainable pest control strategies, will be evaluated as part of the trial work. Residue testing will also be undertaken to develop residue decay curves for the synthetic chemical options trialled. 

ALT transition technical lead Bruno Gatimel.

Many of these products show broad potential across pests, diseases, and crops, meaning insights from one specific trial can still offer valuable benefits to other sectors and the wider industry. 

Pests being targeted through the trials include aphids, whiteflies, caterpillars, moths, beetles and thrips, in both fruit and vegetable crops.  

Some trials are a continuation of work on specific crops’ priority pests, while others are focusing on high priority crop protection control gaps in the trial crops and will contribute to work already underway to identify alternatives for organophosphates and synthetic pyrethroids – chemistry which is being phased out. 

The efficacy and residue trials are occurring in: 

  • Summerfruit for control of Carpophilus beetle 
  • Onions for control of Stemphylium  
  • Lemons for control of thrips 
  • Onions for control of thrips 
  • Sweet corn for control of green vegetable bug 
  • Summerfruit for control of aphids 
  • Sweet corn for control of caterpillars 
  • Brassica for control of moths 
  • Citrus for control of whitefly  

The only trial focusing on residue profiles only is in: 

  • Greenhouse tomatoes to establish a residue decay curve for russet mite miticides. 

When it comes to sharing of results from trials, there are a number of factors to be considered. 

“Our ALT minor use trials include innovative, IP-sensitive products still in the R&D pipeline, making it challenging to share performance data widely due to confidentiality,” Bruno says.  

“To navigate confidentiality constraints in minor use trials, we work closely with product owners and registrants to define what information can be shared and use anonymised or aggregated data to protect IP. This allows us to share meaningful insights across sectors while respecting commercial sensitivities, ensuring broader industry benefit without compromising innovation.” 

 A summary of other completed and in progress ALT projects, and the pests or diseases being targeted can be found on the Our Projects section of the ALT website and by downloading the Quick Reference Guide to project work. 

Leave a Reply